Selective Inhibition of hsp90 Paralogs: Uncovering the Role of Helix 1 in Grp94‐Selective Ligand Binding
Proteins: Structure, Function, and Bioinformatics · 2025
DOI: 10.1002/prot.26756 ↗At a glance
Journal article in Proteins: Structure, Function, and Bioinformatics, 2025. Written by Nanette L S Que and 4 co-authors. Institution: Hauptman Woodward Medical Research Institute, Buffalo, New York, USA. Major MEDLINE topics: HSP90 Heat-Shock Proteins, HSP70 Heat-Shock Proteins, Membrane Glycoproteins. Cited 2 times so far (Crossref); 58 references. The full text is freely available in PubMed Central. Funded by: NIGMS NIH HHS, NIH HHS, NCI NIH HHS.
Abstract (original language)
Grp94 is the endoplasmic reticulum paralog of the hsp90 family of chaperones, which have been targeted for therapeutic intervention via their highly conserved ATP binding sites. The design of paralog‐selective inhibitors relies on understanding the protein structural elements that drive higher affinity in selective inhibitors. Here, we determined the structures of Grp94 and Hsp90 in complex with the Grp94‐selective inhibitor PU‐H36, and of Grp94 with the non‐selective inhibitor PU‐H71. In Grp94, PU‐H36 derives its higher affinity by utilizing Site 2, a Grp94‐specific side pocket adjoining the ATP binding cavity, but in Hsp90 PU‐H36 occupies Site 1, a side pocket that is accessible in all paralogs with which it makes lower affinity interactions. The structure of Grp94 in complex with PU‐H71 shows only Site 1 binding. While changes in the conformation of helices 4 and 5 in the N‐terminal domain occur when ligands bind to Site 1 of both Hsp90 and Grp94, large conformational shifts that also involve helix 1 are associated with the engagement of the Site 2 pocket in Grp94 only. Site 2 in Hsp90 is blocked and its helix 1 conformation is insensitive to ligand binding. To understand the role of helix 1 in ligand selectivity, we tested the binding of PU‐H36 and other Grp94‐selective ligands to chimeric Grp94/Hsp90 constructs. These studies show that helix 1 is the major determinant of selectivity for Site 2 targeted ligands and also influences the rate of ATPase activity in Hsp90 paralogs.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Hauptman Woodward Medical Research Institute, Buffalo, New York, USA.
- Chemical Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
- Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
ORCID profiles: Daniel T Gewirth
Funding
- NIGMS NIH HHS
- NIH HHS
- NCI NIH HHS
- Mae Stone Goode Foundation
- National Institutes of Health
Cite
APA
Que, N. L. S., Seidler, P. M., Aw, W. J., Chiosis, G., & Gewirth, D. T. (2025). Selective Inhibition of hsp90 Paralogs: Uncovering the Role of Helix 1 in Grp94‐Selective Ligand Binding. Proteins: Structure, Function, and Bioinformatics. https://doi.org/10.1002/prot.26756
Vancouver
Que NLS, Seidler PM, Aw WJ, Chiosis G, Gewirth DT. Selective Inhibition of hsp90 Paralogs: Uncovering the Role of Helix 1 in Grp94‐Selective Ligand Binding. Proteins: Structure, Function, and Bioinformatics. 2025. doi:10.1002/prot.26756
BibTeX
@article{Que2025,
author = {Que, Nanette L S and Seidler, Paul M and Aw, Wen J and Chiosis, Gabriela and Gewirth, Daniel T},
title = {Selective Inhibition of hsp90 Paralogs: Uncovering the Role of Helix 1 in Grp94‐Selective Ligand Binding},
journal = {Proteins: Structure, Function, and Bioinformatics},
year = {2025},
doi = {10.1002/prot.26756}
}
EUVIMED